Multiple studies have found elevated levels of cytokeratin-18 (CK-18) fragments in patients with NASH and have shown that elevated levels of CK-18 can be a predictor of NASH in patients with NAFLD [87]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatotic liver disease.